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Leukotactin(Lkn)-1 is a CC chemokine and is upregulated in 
macrophages in response to Mycobacterium tuberculosis (MTB) 
infection. We investigated whether mitogen-activated protein 
kinases (MAPKs) are involved in MTB-induced expression of 
Lkn-1. The up-regulation of Lkn-1 by infection with MTB was 
inhibited in cells treated with inhibitors specific for JNK 
(SP600125) or p38 MAPK (SB202190). Since the up-regulation of 
Lkn-1 by MTB has been reported to be mediated by the 
PI3-K/PDK1/Akt signaling, we examined whether JNK and/or 
p38 MAPK are also involved in this signal pathway. 
MTB-induced Akt phosphorylation was blocked by treatment 
with JNK- or p38 MAPK-specific inhibitors implying that p38 and 
JNK are upstream of Akt. In addition, treatment with the 
PI3-K-specific inhibitor inhibited MTB-stimulated activation of 
JNK or p38 MAPK implying that PI3-K is upstream of JNK and 
p38 MAPK. These results collectively suggest that JNK and p38 
MAPK are involved in the signal pathway responsible for 
MTB-induced up-regulation of Lkn-1. [BMB Reports 2012; 
45(10): 583-588]
INTRODUCTION
Mycobacterium tuberculosis (MTB) is an intracellular pathogen 
and is the causative agent of pulmonary tuberculosis which is 
one of the main causes of morbidity and mortality worldwide 
(1). Infection of human macrophages with MTB induces release 
of a variety of cytokines which participate in protective and im-
mune host responses during human tuberculosis (2-6). Down- 
regulation of cytokine receptors in T cells has been reported to 
result in ineffective control of persisting pathogens such as MTB 
(7). MTB induces the expression of a variety of chemokines such 
as monocyte chemotactic protein-1 (MCP-1), macrophage in-
flammatory protein-1α (MIP-1α), macrophage inflammatory pro-
tein-1β (MIP-1β) and regulated upon activation, normal T-cell ex-
pressed and secreted (RANTES) (8-12). These induced chemo-
kines have been reported to be involved in the inhibition of in-
tracellular MTB growth, formation of granulomas, and the re-
cruitment of lymphocytes and monocytes to pleural cavity in TB 
patients (13-18). 
　Mycobacterial infection induced-expression of a variety of 
chemokines is known to be mediated via various signaling path-
ways (19, 20). However, the signaling pathways by which MTB 
induces production of a variety of cytokines in macrophages are 
not yet fully understood. Recent studies have suggested that the 
mitogen-activated protein kinase (MAPK) pathway is an im-
portant component of mycobacterial pathogenesis (21). The 
MAPK signaling pathway is a highly conserved pathway that is 
important in diverse aspects of the immune response (22-24). 
The MAPK family includes ERK, p38 MAPK, and stress-activated 
protein kinase/c-Jun N-terminal kinase (JNK) (25, 26). Activation 
of p38 MAPK has been reported to be induced in monocytes fol-
lowing infection with MTB (27). In addition, the MAPK signaling 
pathway was shown to be essential for the mycobacterium-in-
duced production of proinflammatory cytokines, such as tumor 
necrosis factor alpha (TNF-α), IL-1β, and MCP-1 (28, 29). 
　Recently, it has been demonstrated that leukotactin-1 (Lkn-1), 
a member of the CC chemokine family, is induced during myco-
bacterial infection implying the association of Lkn-1 with the de-
velopment of tuberculosis. In addition, it has been shown that 
MTB-induced upregulation of Lkn-1 is mediated by the PI3-K/ 
PDK1/Akt signaling pathway (30, 31). However, involvement of 
additional signaling pathways in MTB-induced Lkn-1 regulation 
is unknown. In the present study, we aimed to elucidate the in-
volvement of the MAPK pathway in MTB-induced expression of 
Lkn-1. We demonstrated that p38 MAPK and JNK are associated 
with regulation of Lkn-1 expression in response to MTB infection 
in macrophages. 
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Fig. 1. MTB enhances expression of Lkn-1 and activates MAPKs. (A) 
THP-1 cells were treated with 100 nM PMA for 48 h, and infected 
with MTB (10 MOI) for 4 h. Total RNA was extracted and cDNA 
was prepared. PCR analysis was performed using Lkn-1-specific pri-
mers and the PCR products were resolved by 1.8% agarose gel 
(upper panel). GAPDH was used as an internal control. Densitomet-
ric analysis was performed (lower panel). Data are expressed as 
mean ± SD and are presented as expression levels of Lkn-1 mRNA 
relative to GAPDH mRNA (The expression level of Lkn-1 relative to 
GAPDH in the absence of mycobacterial infection was set to 1.0). 
The data represent results from three independent experiments. 
Statistical analysis was performed by Student’s t-test (***P ＜ 0.001 
relative to uninfected control). (B) Differentiated THP-1 cells were 
starved for 16 h and infected with MTB (10 MOI) for the indicated 
times (0, 15, 30, 60, 120, 180 min) before cell lysates were pre-
pared, Cell lysates were resolved on 12% SDS-polyacrylamide gels 
and transferred to nitrocellulose membranes. Phosphorylation of JNK, 
p38 MAPK, ERK, and Akt was detected by Western blotting using 
anti-phospho-JNK, p38 MAPK, ERK, or Akt, respectively. Beta-actin 
was used as an internal control.
RESULTS AND DISCUSSION
MTB enhances expression of Lkn-1 and activates MAPKs
Our previous study reported the involvement of Lkn-1 in the im-
mune response of macrophages against MTB and revealed that 
MTB infection causes increased expression and secretion of 
Lkn-1 in differentiated THP-1 cells (31). In the present study, we 
reconfirmed the infection of THP-1 cells with MTB induced 
up-regulation of Lkn-1 mRNA (Fig. 1A). Next, we examined 
whether infection with MTB activates protein kinases included in 
the MAPK family which is known to be associated with MTB-in-
duced production of cytokines (22-24). THP-1 cells were treated 
with PMA for 48 h and incubated with MTB for the indicated 
times. Phosphorylation of MAP kinases was detected by Western 
blotting. As shown in a previous report (31), MTB infection acti-
vated Akt (Fig. 1B). In addition, infection of MTB caused phos-
phorylation of MAP kinases including JNK, p38, and ERK (Fig. 
1B). Data showed that MTB-induced phosphorylation of JNK and 
p38 MAPK was detectable 30 min after infection and persisted 
for at least 180 min after MTB infection. This pattern is similar to 
MTB-induced phosphorylation pattern of Akt. In contrast, phos-
phorylation of ERK was detectable 15 min after infection but de-
clined thereafter and was undetectable at 120 min after MTB in-
fection (Fig. 1B). These results suggest that in addition to the pre-
viously identified Akt, MAP kinases may be also involved in 
MTB-induced up-regulation of Lkn-1. 
p38 MAPK and JNK are involved in MTB-stimulated 
up-regulation of Lkn-1
Based on the results above, we determined whether MAP kin-
ases such as JNK, p38, and ERK are associated with MTB-in-
duced expression of Lkn-1. PMA-treated THP-1 cells were 
pre-treated with the JNK inhibitor (SP600125), the p38 inhibitor 
(SB202190), or the MEK1 inhibitor (PD98059) for 45 min before 
exposure to MTB for 4 h. The mRNA level of Lkn-1 was detected 
by semi-quantitative PCR analysis. As shown in Fig. 2, treatment 
with SP600125 (an inhibitor of JNK) or SB202190 (an inhibitor 
of p38 MAPK) abolished MTB-induction of Lkn-1 in an inhibitor 
dose-dependent manner. However, pre-treatment with PD98059 
(an inhibitor of MEK1) did not influence mRNA induction of 
Lkn-1 by MTB (Fig. 2). These data suggests that the p42 and p44 
extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathways 
are not associated with MTB-induced up-regulation of Lkn-1 
since MEK1 is an upstream signaling molecule of ERK1/2. These 
results imply that although JNK, p38, and ERK were all activated 
in response to MTB infection, only JNK and p38 showed associa-
tion with MTB-induced Lkn-1 expression. As shown in Fig. 1, al-
though JNK, p38, and ERK were all activated by infection with 
MTB, the pattern of activation was different between JNK/p38 
MAPK and ERK. Activation of JNK and p38 MAPK persisted for 
at least 3 h after MTB infection which is similar to the activation 
pattern of Akt. However, phosphorylation of ERK disappeared at 
120 min after MTB infection (Fig. 1B). It is possible that pro-
longed activation (for at least more than 3 h) of signaling mole-
cules is required for MTB-induced expression of Lkn-1.           
Lkn-1 induction by infection with MTB is mediated through 
PI3-K to p38/JNK to Akt signaling pathway
We previously demonstrated that the up-regulation of Lkn-1 
caused by MTB infection was mediated by PI3-K, PDK1 and Akt 
(31). Here we determined whether JNK and p38 MAPK activated 
during MTB-induction of Lkn-1 are separate from or part of the 
PI3-K/PDK1/Akt signaling pathway. As shown in Fig. 3A, 
pre-treatment with a JNK inhibitor (SP600125) or p38 inhibitor 
(SB202190) before infection with MTB diminished MTB-induced 
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Fig. 2. p38 MAPK and JNK mediates MTB-induced expression of Lkn-1. PMA-treated THP-1 cells were pre-incubated with the inhibitors 
SB202190 (5 μM, 20 μM, 40 μM), SP600125 (5 μM, 20 μM, 40 μM), PD98059 (5 μM, 20 μM, 40 μM) for 45 min, followed by myco-
bacterial infection (10 MOI) for 4 h. cDNA was prepared from total RNA extracted from treated cells. PCR analysis was performed using 
Lkn-1-specific primers. PCR products were analyzed by 1.8% agarose gel (upper panel) to detect Lkn-1 expression. GAPDH was used as 
an internal control. Densitometric analysis was performed (lower panel). Data are expressed as mean ± SD, and are presented as ex-
pression levels of Lkn-1 mRNA relative to GAPDH mRNA. (The level of Lkn-1 relative to GAPDH in the absence of mycobacterial in-
fection was set to 1.0). The data are results from three independent experiments. Statistical analysis was performed by Student’s t-test. (*P 
＜ 0.05, **P ＜ 0.01 relative to uninfected control).
Fig. 3. MTB-stimulated expression of Lkn-1 is partially mediated through PI3-K to p38/JNK to Akt signaling pathway. (A) PMA-treated 
THP-1 cells were starved for 16 h, and treated with SP600125 (20 μM) or SB202190 (20 μM) for 45 min. Subsequently, cells were in-
fected with MTB (10 MOI) for the indicated times before cell lysates were prepared, resolved on 12% SDS-polyacrylamide gels and trans-
ferred to nitrocellulose membranes. Akt phosphorylation was determined by Western blotting using anti-phopho-Akt antibody. Differentiated 
THP-1 cells were starved for 16 h, and treated with Ly294002 (20 μM) or OSU03012 (5 μM) for 45 min. Subsequently, cells were in-
fected with MTB (10 MOI) for the indicated times before cell lysates were prepared. Phosphorylation of p38 MAPK (B) or JNK (C) was 
determined by Western blotting using anti-phopho-p38 MAPK and anti-phopho-JNK antibody, respectively. Beta-actin was used as an in-
ternal control. 
phosphorylation of Akt. The levels of phosphorylated p38 MAPK 
and JNK were not affected by pre-treatment with the Akt in-
hibitor before stimulation with MTB (data not shown). These re-
sults show that JNK and p38 are upstream molecules of Akt in 
the signaling pathway.
　In addition, differentiated THP-1 cells were pre-treated with 
Ly294002 (PI3-K inhibitor) or OSU03012 (PDK1 inhibitor) be-
fore exposure to MTB and phosphorylation of JNK and p38 
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Fig. 4. The schematic model showing signal transduction pathway 
associated with MTB-induced expression of Lkn-1. 
MAPK was assessed. Ly294002 treatment partially prevented 
phosphorylation of JNK and p38 MAPK (Fig. 3B and C, middle 
panel). In contrast, inhibition of PDK1 did not influence the lev-
els of phosphorylated JNK and p38 MAPK (Fig. 3B and C, right 
panel). These data suggest that PI3-K is an upstream kinase of 
p38 MAPK and JNK in the signal pathway associated with 
up-regulation of Lkn-1 by MTB infection. In contrast, PDK1 does 
not seem to be an upstream molecule of p38 MAPK or JNK in 
this signal pathway. These results imply that increased ex-
pression of Lkn-1 in response to MTB infection is mediated via 
three pathways: the PI3-K/PDK1/Akt, PI3-K/p38 MAPK/Akt, and 
the PI3-K/JNK/Akt signaling pathways (Fig. 4). Further studies are 
needed to determine if JNK and p38 MAPK are upstream mole-
cules of PDK1.
　In conclusion, in addition to the previously reported PI3-K/ 
PDK1/Akt pathway, we identified two additional signaling mole-
cules, p38 MAPK and JNK, involved in MTB-induced Lkn-1 ex-
pression in PMA-differentiated THP-1 cells. The elucidation of 
the signaling pathways involved in MTB-induced Lkn-1 ex-
pression during tuberculosis development may provide useful in-
formation which can be exploited for therapeutic intervention.
MATERIALS AND METHODS
Materials 
Specific inhibitors of p38 MAPK (SB202190), MEK1 (PD98059), 
JNK (SP600125), PI3-K (Ly294002) were purchased from Calbio-
chem (San Diego, CA, USA). Specific inhibitors of PDK1 (OSU-
03012) were purchased from Cayman (Ann Arbor, MI, USA). 
Dimetyl sulphoxide (DMSO) was obtained from Sigma-Aldrich (St. 
Louis, MO, USA).  
Preparation of mycobacteria
MTB H37Rv (ATCC 27294) used in this study was grown for 
about four weeks at 37°C as a surface pellicle on Sauton me-
dium enriched with 0.4% sodium glutamate and 3.0% glycerol. 
The surface pellicles were collected and disrupted by gentle vor-
texing with 6 mm glass beads. After clumps were settled, the up-
per suspension was collected and aliquots were stored at 
−80oC. Before infection, aliquots were thawed and quantitated 
for viable colony-forming units (CFU) on Middlebrook 7H10 
agar (Difco, Detroit, MI, USA).
Cell culture and infection of MTB
The THP-1 cells were maintained in RPMI 1640 medium with 2 
mM glutamine, 10% heat inactivated fetal bovine serum, 100 
U/ml penicillin and 100 μg/ml streptomycin (Gibco-BRL, Grand 
Island, NY, USA) at 37oC under 5% CO2. THP-1 cells were seed-
ed in six-well plates and treated with 100 nM phorbol-12-myr-
istate-13-acetate (PMA; Sigma) for 48 h to induce differentiation 
into macrophage-like cells, then washed three times with RPMI 
1640 medium. Before infection, differentiated THP-1 cells were 
reconstituted in antibiotic free RPMI 1640 medium with 10% 
FBS. PMA-differentiated THP-1 cells were pretreated with in-
hibitors for 45 min before stimulation with MTB H37Rv for 4 h 
at MOI 10.
RNA extraction and semi-quantitative reverse transcriptase 
PCR (RT-PCR)
After removing nonphagocytosed bacilli, total RNA was extracted 
from cultured cells using Trizol reagent (Invitrogen, Carlsbad, CA, 
USA) according to the manufacturer’s instructions. cDNA was 
synthesized by reverse transcription with 2 μg total RNA, 0.25 μg 
of random hexamer (Invitrogen) and 200 unit of Murine Molony 
Leukemia Virus Reverse Transcriptase (MMLV-RT; Invitrogen) for 
50 min at 37oC and 15 min at 70oC. Subsequent PCR amplifica-
tion using 0.2 units of Taq polymerase (Cosmo Genetech, Seoul, 
Korea) was performed in a thermocycler (Applied Biosystems, 
Foster city, CA, USA) for 40 cycles (94oC for 30s, 55oC for 30s, 
72oC for 30s) using the Lkn-1 primer (sense 5 -´CCTCTCCTG 
CCTCATGCTTA-3 ,´ antisense 5 -´ACTGGGTTTGGCACAGACTT- 
3 )´. GAPDH was amplified as an internal control with primers 
(sense 5 -´CGGGAAGCTTGTGATCAATGG-3 ,´ antisense 5 -´GG 
CAGTGATGGCATGGACTG-3 )´. PCR products were electro-
phoresed on 1.8% (w/v) agarose gels containing 0.5 μg/ml ethi-
dium bromide, and the sizes of the products were determined by 
comparison to the 100 bp DNA ladder marker (Bioneer, Daejeon, 
Korea). The intensity of each band amplified by RT-PCR was ana-
lyzed using Gel Doc EQ Quantity One (version 4.5, Bio-Rad, 
Milan, Italy) and normalized to GAPDH mRNA in corresponding 
MTB induces Lkn-1 via JNK and p38 MAPK 




PMA-differentiated THP-1 cells were grown in six-well plates 
and were starved for 16 h, pretreated with inhibitors for 45 min, 
then infected with MTB for 0, 15, 30, 60, 120 or 180 min. After 
incubation, cells were washed twice in ice-cold phosphate-buf-
fered saline (PBS) and solubilzed in lysis buffer containing 10 
mM Tris (pH 7.0), 140 mM NaCl containing proteinase in-
hibitors (Roche, Basel, Switzerland) and phophatase inhibitor(s) 
(Thermo scientific, Waltham, MA, USA). Samples of equal 
amounts of protein (40 ug) were subjected to sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE), and 
transferred to a nitrocellulose membrane. The membrane was 
blocked in Tris- buffered saline with 0.1% Tween-20 (TBST) buf-
fer containing 5% non- fat milk. Also, immunoblotting was per-
formed with anti-phospho-Akt (Ser473), p38 MAPK (Thr180/ 
Tyr182), JNK (Thr183/Tyr185), or ERK (Thr202/Tyr204) (Cell 
Signaling Technology, Danvers, MA, USA) (32). Immunoreac-
tive proteins were detected by horseradish peroxidase-con-
jugated secondary antibody (Jackson Immunoresearch Laborato-
ries, West Grove, PA, USA). The blot was developed with a 
chemiluminescent system (Pierce, Rockford, IL, USA).
Statistics
All values are given as mean ± standard deviation (SD). When a 
significant difference was detected, further analysis was per-
formed using a Student’s t-test. A P value of less than 0.05 was 
considered significant (GraphPad Prism 4 Software, SanDiego, 
CA, USA)
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